Lanny Gore, MD
Surgery · New Albany, INNPI 1194886689
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.6% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $15,473 and has fallen 88.8% since, to $1,738 in 2025. Among surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $228.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$29K
- Davol Inc.$1K
- Medtronic$1K
- Baxter Healthcare$1K
- Apollo Endosurgery US Inc$672
- Standard Bariatrics, Inc.$629
- plus $1K from 20 others
What the payments were for
- Consulting fees$4001%
- Speaking & faculty fees$3,85011%
- Travel & lodging$6,98920%
- Food & beverage$4,88114%
- Education$19,55255%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 55 | $29,448 |
| Davol Inc. | 11 | $1,278 |
| Medtronic | 16 | $1,169 |
| Baxter Healthcare | 21 | $1,048 |
| Apollo Endosurgery US Inc | 7 | $672 |
| Standard Bariatrics, Inc. | 4 | $629 |
| Johnson & Johnson | 6 | $311 |
| Integra Lifesciences Corporation | 1 | $157 |
| Novo Nordisk | 7 | $139 |
| Teleflex LLC | 1 | $117 |
| Stryker | 1 | $114 |
| Heron Therapeutics, Inc. | 3 | $96 |
| KARL Storz Endoscopy-america | 2 | $90 |
| W. L. Gore & Associates, Inc. | 3 | $72 |
| Sanara Medtech Inc. | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $58 |
| Acacia Pharma Inc | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Olympus America Inc. | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Eagle Pharmaceuticals, Inc. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $18 |
| Merck | 1 | $17 |
| TELA Bio, Inc. | 1 | $15 |
| Ambu Inc. | 1 | $11 |
| Avanos Medical | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$25,744
- DAVINCI XI$2,500
- LigaSure$735
- TITAN SGS STANDARD GASTRIC STAPLER$525
- DA VINCI SP$500
- INTEGRA$470
- OverStitch Endoscopic Suturing System$375
- INTEGRA DERMAL REGENERATION TEMPLATE$157
- PRIMATRIX$157
- TISSEEL$125
- PERI-STRIPS DRY$120
- TITAN SGS BAILOUT CHUCK$117
- SPY-PHI SYSTEM$114
- FLOSEAL$112
- ECHELON ENDOPATH Stapler$105
- ENSEAL Product Family$105
- Signia$105
- SEPRAFILM$103
How this compares
$35,672 in reported general payments places this provider in the 95th percentile of 524 surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 27 | $28,731 |
| EliquisApixaban | 11 | $2,865 |
| Ursodiol | 23 | $1,404 |
| Ondansetron OdtOndansetron | 55 | $1,128 |
| Omeprazole | 69 | $325 |
| Promethazine Hcl | 16 | $95 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $52 |
| Famotidine | 13 | $36 |
| Hydromorphone Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $34 | $28,73127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 524 surgery providers in Indiana.
Other surgery in New Albany
- Paul SzotekIndianapolis$2.4M
- Carlos Gonzalez RendonMunster$275K
- Anthony ZappiaCarmel$105K
- Jeremy Luedtkela Porte$102K
- Patricia ClarkFort Wayne$82K
- Erica GiblinCarmel$70K
- Paul BowldsGreenwood$69K
- Michael MillerIndianapolis$53K
- M ShabeebMunster$48K
- Sandra WischmeyerMichigan City$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.